Cephalosporin Market 2023-2028: Size, Share, Top Manufacturers, Growth, Trends, and, Industry Forecast Report

The latest report by IMARC Group, titled "Cephalosporin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028", offers a comprehensive analysis of the industry, which comprises insights on the global cephalosporin market. The report also includes competitor and regional analysis, and contemporary advancements in the market.

The global cephalosporin market size reached US$ 18.7 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 22.3 Billion by 2028, exhibiting a growth rate (CAGR) of 2.83% during 2023-2028.

Cephalosporin belongs to a class of antibiotics that is used to treat a wide variety of bacterial infections. It is derived from a fungus known as cephalosporium and is a beta-lactam antibiotic that functions in a way similar to penicillin. It generally works by disrupting the production of bacterial cell walls, which prevents the bacteria from growing and multiplying. It is well tolerated by patients and can treat numerous infections, including ear and skin infections and pneumonia, and meningitis. At present, there are five generations of commercially available cephalosporin drugs with a slight difference in their antibacterial spectrum.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request Free Sample Report: https://www.imarcgroup.com/cephalosporin-market/requestsample

Market Trends and Drivers:

The rising health consciousness among the masses majorly drives the global market. This can be attributed to the accelerating prevalence of bacterial infections, such as kidney infections, meningitis, pneumonia, bone infections, urinary tract infections, sepsis, gonorrhea, and sexually transmitted diseases (STDs) among individuals. Apart from this, the extensive use of cephalosporin with other antibiotics, such as amoxicillin or clindamycin, to enhance the effectiveness of the treatment is propelling the market. Moreover, continuous technological advancements in the development of novel cephalosporin drugs are creating a positive market outlook. Some of the other factors driving the market include extensive research and development (R&D) activities, the rising geriatric population and increasing healthcare expenditure.

Explore the Full Report with TOC & List of Figures: https://www.imarcgroup.com/cephalosporin-market

Competitive Landscape:

The competitive landscape of the market has been studied in the report with detailed profiles of the key players operating in the market.

Some of these key players include:

• Allergan Plc
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche Ltd.
• GlaxoSmithKline plc
• Lupin Limited
• Merck & Co. Inc.
• Novartis International AG (Sandoz)
• Pfizer Inc.
• Sanofi
• Teva Pharmaceutical Industries Ltd.
• Abbott
• Sun Pharmaceutical Industries Limited

Key Market Segmentation:

Breakup by Generation:

• First Generation
• Second Generation
• Third Generation
• Fourth Generation
• Fifth Generation

Breakup by Route of Administration:

• Injection
• Oral

Breakup by Application:

• Respiratory Tract
• Skin Infection
• Ear Infection
• Urinary Tract Infection
• Sexually Transmitted Infection
• Others

Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key highlights of the Report:

• Market Performance (2017-2022)
• Market Outlook (2023-2028)
• COVID-19 Impact on the Market
• Porter's Five Forces Analysis
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

TOC for the Report:

• Preface
• Scope and Methodology
• Executive Summary
• Introduction
• Global Market
• SWOT Analysis
• Value Chain Analysis
• Price Analysis
• Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Read Latest Research Reports by IMARC Group:

• Halal Food Market Report 2023: https://www.imarcgroup.com/halal-food-market

• Rolling Stock Market Report 2023: https://www.imarcgroup.com/rolling-stock-market

• Hot Sauce Market Report 2023: https://www.imarcgroup.com/hot-sauce-market

• Shrimp Market Report 2023: https://www.imarcgroup.com/prefeasibility-report-shrimp-processing-plant

• Process Analyzer Market Report 2023: https://www.imarcgroup.com/process-analyzer-market

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.